Management of Inflammatory Bowel Disease with Infliximab and Other Anti-Tumor Necrosis Factor Therapies: Review of Literature and Case Reports FOREWORD

被引：0
|
作者：
Magro, Fernando [1 ,2 ,3 ]
机构：
[1] Portuguese Grp Studies Inflammatory Bowel Dis, Oporto, Portugal
[2] Hosp Sao Joao, Dept Gastroenterol, Oporto, Portugal
[3] Univ Porto, Fac Med, Inst Pharmacol & Therapeut, P-4003 Oporto, Portugal
来源：
BIODRUGS | 2010年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [1] Management of Inflammatory Bowel Disease with Infliximab and Other Anti-Tumor Necrosis Factor Alpha Therapies
    Fernando Magro
    Francisco Portela
    BioDrugs, 2010, 24 : 3 - 14
  • [2] Management of Inflammatory Bowel Disease with Infliximab and Other Anti-Tumor Necrosis Factor Alpha Therapies
    Magro, Fernando
    Portela, Francisco
    BIODRUGS, 2010, 24 : 3 - 14
  • [3] Strategies for overcoming anti-tumor necrosis factor drug antibodies in inflammatory bowel disease: Case series and review of literature
    Mansi M Kothari
    Douglas L Nguyen
    Nimisha K Parekh
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2017, (03) : 155 - 161
  • [4] Anti-Tumor Necrosis Factor α-Related Psoriatic Lesions in Children with Inflammatory Bowel Disease: Case Report and Systematic Literature Review
    Romiti, Ricardo
    Araujo, Karin Milleni
    Steinwurz, Flavio
    Denadai, Rafael
    PEDIATRIC DERMATOLOGY, 2016, 33 (02) : E174 - E178
  • [5] Update on anti-tumor necrosis factor agents and other new drugs for inflammatory bowel disease
    Cohen, Benjamin L.
    Sachar, David B.
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 357
  • [6] Optimizing anti-tumor necrosis factor strategies in inflammatory bowel disease
    William J. Sandborn
    Current Gastroenterology Reports, 2003, 5 (6) : 501 - 505
  • [7] Anti-tumor Necrosis Factor Agents and Tuberculosis in Inflammatory Bowel Disease
    Yunho, Jung
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2020, 75 (01): : 1 - 3
  • [8] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
    Frank Hoentjen
    Ad A van Bodegraven
    World Journal of Gastroenterology, 2009, 15 (17) : 2067 - 2073
  • [9] Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
    Hoentjen, Frank
    Van Bodegraven, Ad A.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (17) : 2067 - 2073
  • [10] Crohn's disease: future anti-tumor necrosis factor therapies beyond infliximab
    Korzenik, JR
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (02) : 285 - +
12345